Abstract
Viviana Perez, APRN, FNP-C, of Moffitt Cancer Center, considers findings presented at the 2024 ASH Annual Meeting on patient experiences with bispecific antibodies for diffuse large B-cell lymphoma and the efficacy of CAR T-cell therapy in patients with transformed indolent lymphoma. Laura Zitella, MS, RN, ACNP-BC, AOCN, UCSF, evaluates studies on omitting autologous transplant for many patients with mantle cell lymphoma, the use of CD19-directed monoclonal antibodies in relapsed/refractory follicular lymphoma, and the duration of lenalidomide maintenance in multiple myeloma.
Visit https://jadpro.com/videos/meeting-highlights/ for short videos about these important abstracts.
